相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions
Konstantia Angelidou et al.
CLINICAL TRIALS (2020)
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial
Patricia M. Flynn et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Human Immunodeficiency Virus Antiretroviral Resistance and Transmission in Mother-Infant Pairs Enrolled in a Large Perinatal Study
Nava Yeganeh et al.
CLINICAL INFECTIOUS DISEASES (2018)
Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial
Risa M. Hoffman et al.
HIV CLINICAL TRIALS (2018)
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014
Rachel A. Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission
Ruth Kanthula et al.
AIDS (2017)
Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping
Molly Levine et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Challenges in the Elimination of Pediatric HIV-1 Infection
Katherine Luzuriaga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
M. G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis
Julie A. E. Nelson et al.
AIDS (2015)
High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil
Maria de Lourdes Teixeira et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2015)
Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants
Jessica M. Fogel et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis
Jean B. Nachega et al.
AIDS (2012)
Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis
Jessica Fogel et al.
AIDS (2011)
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
Gillian M. Hunt et al.
AIDS (2011)
Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended Nevirapine Prophylaxis for Prevention of Mother-to-Child HIV Transmission
Deborah Persaud et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis
Clement Zeh et al.
PLOS MEDICINE (2011)
Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance
Elise Arrive et al.
AIDS (2010)
Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1
Francois Dabis
AIDS (2009)
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D
Susan H. Eshleman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana
Roger L. Shapiro et al.
AIDS (2006)
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine
EJ Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
SH Eshleman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012)
SH Eshleman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study)
SH Eshleman et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections
GC John et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission
R Chuachoowong et al.
JOURNAL OF INFECTIOUS DISEASES (2000)